Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 2015

View Archived Issues

Indivior presents phase III results for once-a-month risperidone in schizophrenia

Portola collaborates with Ora on development of PRT-2761 for ophthalmic diseases

Specific Treg inhibition enhances antitumoral effect of DC vaccination in HCC

NanoString Technologies and CITN collaborate on biomarkers for cancer immunotherapy

Pacific Biosciences achieves new milestone in Roche collaboration

World Lupus Day May 10th: Natural product astilbin shows promise in animal model

Transition Therapeutics licenses SARM TT-701 from Lilly

Silver Creek Pharmaceuticals receives grant to develop Smart Growth Factors

Alexion to acquire Synageva

Lundbeck updates progress of first quarter 2015

Preclinical and first clinical data reported for cancer candidate PQR-309

Transplant Genomics awards grant to study organ transplant biomarkers

Symbiomix Therapeutics reports results from phase II trial of SYM-1219 in bacterial vaginosis

BGB-283 shows promising antitumor activity

Phosphate Therapeutics releases phase II results for PT-20 in hyperphosphatemia

EMA committee recommends approval of new Orfadin formulations

Takeda patents OX1 receptor antagonists

Zealand Pharma and Boehringer Ingelheim disclose glucagon analogues

Hospital for Special Surgery reports compositions to promote tissue mineralization

Roche reports development of tau-PET imaging agents

Retinitis pigmentosa gene slc7a14 plays relevant role in vision

Venetoclax receives breakthrough therapy designation in 17p deletion CLL

Sumitomo Dainippon Pharma and Takeda terminate lurasidone agreement

Gilead Sciences acquires EpiTherapeutics

Sucampo's cobiprostone granted fast track designation for oral mucositis

PlasmaTech to acquire Abeona Therapeutics

Zykadia approved in E.U. for ALK-positive NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...